Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Heliyon|April 24, 2023
Tourism-type ontology framework for tourism-type classification, naming, and knowledge organizationPuwei Zhang, Jia Wang, Rui LiInternational Journal of Environmental Research and Public Health|March 16, 2018
Estimation of PM2.5 Concentration Efficiency and Potential Public Mortality Reduction in Urban ChinaAnyu Yu, Guangshe Jia, Jianxin You, et al.Behavioral Sciences (Basel, Switzerland)|October 26, 2022
Formation Mechanisms of Rural Summer Health Destination Loyalty: Exploration and Comparison of Low- and High-Aged Elderly Leisure Vacation TouristsPuwei Zhang, Shuaifeng Guo, Li Zeng, et al.International Journal of Environmental Research and Public Health|January 11, 2022
Spatial-Temporal Pattern and Evolution Trend of the Cultivated Land Use Eco-Efficiency in the National Pilot Zone for Ecological Conservation in ChinaZhenggen Fan, Chao Deng, Yuqi Fan, et al.Phytotherapy Research : PTR|December 24, 2021
Quercetin attenuates the cardiotoxicity of doxorubicin-cyclophosphamide regimen and potentiates its chemotherapeutic effect against triple-negative breast cancerPuwei Zhang, Jianing Zhang, Lin Zhao, et al.Heliyon|October 9, 2024
Analysis of the spatio-temporal variability and convergence of green development efficiency of city clusters in the middle reaches of the Yangtze River in ChinaHaifang He, Hongrui Wang, Hui Lin, et al.Journal of Biochemical and Molecular Toxicology|September 4, 2020
Tanshinone II A improves the chemosensitivity of breast cancer cells to doxorubicin by inhibiting β-catenin nuclear translocationShizheng Li, Chunxia Wu, Chenxing Fan, et al.International Journal of Occupational Safety and Ergonomics : JOSE|December 25, 2021
Psychological decision-making process of construction worker safety behavior: an agent-based simulation approachChangquan He, Guangshe Jia, Brenda McCabe, et al.Journal of Biochemical and Molecular Toxicology|September 13, 2024
Tanshinone IIA potentiates the chemotherapeutic effect of doxorubicin against breast cancer cells and attenuates the cardiotoxicity of doxorubicin by regulating ERK1/2 pathwayShizheng Li, FeiyuTeng, Jianing Zhang, et al.Pageof 1